[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352790-105":59,"doc-detail-352790-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","enhancing-diagnostic-pathways-for-bronchopulmonary-neuroendocrine-tumors-assessment-of-the-south-wales-neuroendocrine-tumor-service-transformation","Enhancing Diagnostic Pathways for Bronchopulmonary Neuroendocrine Tumors: Assessment of the South Wales Neuroendocrine Tumor Service Transformation","","Bronchopulmonary neuroendocrine tumors (bpNETs) are uncommon lung neoplasms that create diagnostic and treatment difficulties. This retrospective study assesses how transforming the South Wales Neuroendocrine Cancer Service affects diagnostic and management outcomes for typical and atypical carcinoids diagnosed before versus after the September 2017 service change. Median pathway times from presentation to diagnosis, symptom onset to diagnosis, and presentation to treatment decreased significantly, while other measures remained similar; additional trends included more incidental diagnoses and increased diagnostic test use.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/enhancing-diagnostic-pathways-for-bronchopulmonary-neuroendocrine-tumors-assessment-of-the-south-wales-neuroendocrine-tumor-service-transformation/352790/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/enhancing-diagnostic-pathways-for-bronchopulmonary-neuroendocrine-tumors-assessment-of-the-south-wales-neuroendocrine-tumor-service-transformation/352790.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address for bronchopulmonary neuroendocrine tumors (bpNETs)?","Question",{"text":112,"@type":113},"bpNETs are uncommon lung tumors with nonspecific symptoms, which can lead to diagnostic complexity and potential delays. The study targets improvements in diagnostic and management pathways through service transformation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What change was implemented in the South Wales service in September 2017?",{"text":117,"@type":113},"The transformation introduced consultant-led NET clinics, regular multidisciplinary team (MDT) meetings, increased communication via trained cancer nurse specialists, and collaborative relationships with local respiratory and oncology colleagues.",{"name":119,"@type":110,"acceptedAnswer":120},"Which diagnostic pathway times improved after the transformation?",{"text":121,"@type":113},"After the transformation, median times from presentation to diagnosis, symptom onset to diagnosis, and presentation to treatment decreased significantly. No other significant differences were reported between pre- and post-transformation groups.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352790,1790900321,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Thoracic Cancer   \n ORIGINAL ARTICLE  OPEN ACCESS   \nEnhancing Diagnostic Pathways for Bronchopulmonary Neuroendocrine Tumors: Assessment of the South Wales Neuroendocrine Tumor Service Transformation  \nArouba Imtiaz1  | Oliver Burbidge2 | Mat Jones3 | Robin Ghosal4 | Janardhan Navaratnam1 | Craig Dyer2 | Helen E. Davies2 | Mohid S. Khan1   \n1South Wales Neuroendocrine Cancer Service, Department of Gastroenterology, University Hospital of Wales, Cardiff, UK | 2Department of Respiratory Medicine, Cardiff and Vale University Health Board, Cardiff, UK | 3Department of Respiratory Medicine, Nevill Hall Hospital, Abergavenny,  \nUK | 4Department of Respiratory Medicine, Prince Philip Hospital, Llanelli, UK  \nCorrespondence: Mohid S. Khan ([khanms14@cardiff.ac.uk](khanms14@cardiff.ac.uk))  \nReceived: 4 June 2025 | Revised: 8 March 2026 | Accepted: 8 April 2026  \nABSTRACT  \nBackground: Bronchopulmonary neuroendocrine tumors (bpNETs) are uncommon lung neoplasms posing significant diagnostic and therapeutic challenges. This study evaluates the impact of the transformation of the South Wales Neuroendocrine Cancer Service on diagnostic and management outcomes for bpNETs.  \nMethods: We retrospectively analyzed data from patients with typical and atypical carcinoids (TC and AC) diagnosed before and after commissioned service transformation (September 2017) . Data were collected from network cancer databases and clinical portals. Demographics, diagnostic pathway times, diagnostic tests, treatment modalities, and survival outcomes were analyzed. Results: Following transformation, significant reductions were observed in median times from presentation to diagnosis (p = 0.009), symptom onset to diagnosis (p = 0.006), and presentation to treatment (p = 0.020) . No other significant differences were noted between pre-and post-transformation groups. Incidental diagnoses increased, especially in TCs (53%). Usage ofCgA, HIAA, EBUS biopsies, and Gallium PET scans increased post-transformation. Surgical treatments were common, but there was an increase in systemic therapy post-transformation.  \nConclusion: Implementation of a collaborative care model and NET service transformation led to significant improvements in pathway times. This is one of the few studies describing such improvements in NETs. While survival outcomes showed promising trends, further research is needed to assess the long-term impact on patient outcomes.  \n1 | Introduction  \nBronchopulmonary neuroendocrine neoplasms (NENs) are uncommon malignancies with an incidence of 0.2–2 per 100 000 [1] . These tumors account for approximately 25% of all lung cancers, comprising 20% small cell carcinoma, 3% large cell carcinoma, 1.8% typical carcinoids (TC), and 0.2% atypical carcinoids (AC), the latter two also known as neuroendocrine tumors (NETs) [2]. Although grouped together, the World Health Organization classifies bronchopulmonary NETs (bpNETs) into two categories based on histopathology review, mitotic rate, and  \nnecrosis, and although not mandated, Ki-67 expression, as mentioned in European NET Society guidelines for NETs from the gastrointestinal tract [1, 3] . Well-differentiated tumors include TC and AC, while poorly differentiated tumors include small and large cell carcinomas [3] with major clinical, epidemiologic, histologic, and genetic differences between the two categories. Notably, TC exhibits a higher 5-year survival rate, ranging from 87% to 94%, compared to small cell lung cancer of 14.3% and large cell lung cancer of 9.6%[4, 5] . In this article, we consider only well-differentiated TCs and ACs ofthe lung, which we will refer to as bpNET.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s) . Thoracic Cancer published by John Wiley & Sons Australia, Ltd.  \nThoracic Cancer, 2026; 17:e70282 1 of 10  \n[ht","cbCaici1Ln5kwWNL","https://ap.wps.com/l/cbCaici1Ln5kwWNL","pdf",760343,"English","# Abstract\n# Introduction","[{\"question\":\"What problem does the study address for bronchopulmonary neuroendocrine tumors (bpNETs)?\",\"answer\":\"bpNETs are uncommon lung tumors with nonspecific symptoms, which can lead to diagnostic complexity and potential delays. The study targets improvements in diagnostic and management pathways through service transformation.\"},{\"question\":\"What change was implemented in the South Wales service in September 2017?\",\"answer\":\"The transformation introduced consultant-led NET clinics, regular multidisciplinary team (MDT) meetings, increased communication via trained cancer nurse specialists, and collaborative relationships with local respiratory and oncology colleagues.\"},{\"question\":\"Which diagnostic pathway times improved after the transformation?\",\"answer\":\"After the transformation, median times from presentation to diagnosis, symptom onset to diagnosis, and presentation to treatment decreased significantly. No other significant differences were reported between pre- and post-transformation groups.\"}]","Enhancing Diagnostic Pathways for Bronchopulmonary Neuroendocrine Tumors: Assessment of the South Wales Neuroendocrine Tumor Service Transformation | PDF",1790101382,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50fd2b606aeb3a2fe08e324d5b501b79.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cfc2a433079690dde1cc1b77972603e.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e56c9ae0eff8d3c59e36e0e5d483777.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa977c05c22f31247746d87a8c0622c0.webp",980,1287]